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Summary-Morphine and related opioid compounds are known to possess proconvulsant activity based 
upon both electroencephalographic and behavioral criteria. The present authors previously suggested 
that opiate-related seizures were behaviorally inhibitory, and this was further investigated in the present 
study. The effects of pretreatment with three pharmacologically distinct compounds (sodium valproic 
acid, trimethadione, taurine) upon normal behavioral activation to systemic morphine were examined in 
the mouse. Morphine consistently increased activity levels in comparison with vehicle. Each of the three 
experimental compounds itself was behaviorally inhibitory; nonetheless both sodium valproate and 
trimethadione facilitated behavioral responses to morphine. The effects of the same drugs upon acti- 
vation produced by central administration of a long-lasting enkephalin analog (o-ala’-leu-enkephalina- 
mide) were investigated, with similar results. These findings confirm a behavioral interaction between 
opiate and anticonvulsant drugs, although it may be selective for certain classes of anticonvulsant 
compounds. 
Previous studies (Cookson and Mann, 1978; Katz 
and Schmaltz, 1979) have proposed the existence of 
behavioral interactions between endogenous and ex- 
ogenous opiates and anticonvulsant drugs, with anti- 
convulsants facilitating behavioral activation to 
opiates. It may be inferred that some property of 
opiates, possibly related to seizures, normally inhibits 
at least certain classes of behavior and this addition- 
ally supported electroencephalographically (e.g. Urea, 
Frenk, Liebeskind and Taylor, 1977; Tortella, More- 
ton and Khazan, 1978). To date, only a limited 
number of ~ticonvulsants have been evafuated for 
their effects upon opiates, either behaviorally or elec- 
troencephalographicaiiy. Given the range of anticon- 
v&ant drugs with both related and distinctive modes 
of action, the generality of effects across drug cate- 
gories might merit additional examination and com- 
ment. 
To investigate the presence and generality of pre- 
viously reported behavioral interadtions, opiate and 
opioid running after pretreatment with a variety of 
anticonvulsant drugs was examined. In particular, 
the pharmacolo~cally distinct ~ticonvuisants, 
sodium valproate, trimethadione and taurine were 
examined for their effects upon behavioral activation 
induced either by systemic morphine or by central 
injection of a long-lasting enkephalin analog (D-ala’- 
leu-enkephalinamide). 
Examination of enkephalin analogs may shed 
further tight upon the reported behavioral effects. The 
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use of analogs allows examination of the generality of 
the reported interaction across opioid classes and 
may enable further specification of the mechanisms 
underlying their effects. For example, one possible 
explanation of results based upon systemic opiate ad- 
ministration is essentially pharmacokinetic in nature. 
The behaviorally effective anticonvulsants may have 
affected morphine disposition in a manner permitting 
altered tissue levels, including brain levels, thereby 
producing a changed behavioral effect. Such effects 
are ruled out in the present design since enkephalin 
injections were central, standardized and directed to a 
single tissue, thereby eliminating effects due to altered 
disposition across tissues. 
METHODS 
Subjects 
Adult male Swiss-Webster mice, 30-3.5 g each, were 
group housed with food (Teklad 4.0% fat rodent diet 
S-0836) and tap water continuously available and a 
12 hr/lZ hr light-dark cycle (lights on = 0700-1900). 
Cell sample sizes for the first experiment (based upon 
systemic morphine) were PI = 36, run as 9 cells of 
grouped mice (n = 4,lcagef per data point. In the ex- 
periment involving central enkephalin injections, each 
data point was based upon 5 mice, run individually. 
The use of grouped mice in assessing morphine effects 
upon activity is a standard procedure in this and 
other laboratories (e.g. Katz and Schmaltz, 1979). 
Surgery 
For the enkephalin injections, mice were anesthe- 
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tized with sodium pentobarbital (Nembutal 50 mg/kg, 
i.p.) and stereotaxically implanted with permanently 
indwelling 23 gauge stainiess-steel cannulae as pre- 
viously described (Katz, Carroll and Baldrighi. 1978). 
Each cannula was located in the lateral cerebral ven- 
tricle, based upon coordinates of - 2.2, - 1.0, 
-2.2 mm posterior, lateral and dorsal from the 
Bregma suture. One week was routinely allowed for 
recovery from surgery. 
Apparatus 
Testing apparatus and sensitivity settings were 
essentially similar to previous reports (Katz and 
Schmaltz, 1979). In brief, activity was measured upon 
four commercially available tuned oscillators operat- 
ing upon a capacitance sensing principle (Stoelting, 
Chicago). Monitors were initially calibrated to within 
5% of each other by measuring the activity of a single 
group of morphine (50mg/kg)-injected mice and 
adjusting to a common score at 30 min post-injection. 
Final values were calibrated based upon detector 
levels of 20 and an intermediate (i.e. N) level trigger 
reset function. Mice were tested as individuals or 
groups in 51 x 41 x 22 cm polypropylene cages 
(Scientific Products Series 70) placed directly upon 
the sensing devices. A bedding of fresh pine chips was 
placed in each cage prior to the introduction of the 
subject. Additional details of apparatus and pro- 
cedure are available in Katz et al. (1978) and Katz 
and Schmaltz (1979). 
Behavioral procedure 
Grouped or individual for enkephalin injections, 
the mice were initially habituated to apparatus place- 
ment and injection (0.9% sodium chloride, lOml/kg) 
procedures in 8 sessions each of 4-6 hr duration. On 
the test day, subjects were placed on the apparatus 
beginning at 080@0900 hr. Five hours were allowed 
for further and final habituation before testing, at 
which point subjects were briefly removed and 
injected with vehicle or anticonvulsant. Thirty min- 
utes later mice were injected with vehicle or opiate. 
Experimental recording continued for ten consecutive 
10 min blocks. 
Drugs 
Morphine sulfate was injected intraperitoneally 
50 mg/kg. D-Ala*-leu-enkephalinamide (prepared 
fresh or stored at 4°C for less than 24 hr in poly- 
propylene containers) was injected 12.5 or 25 pg/ 
mouse in 5 ~1 of 0.9% sodium chloride solution. Cen- 
tral injections were administered manually via a 
Hamilton microsyringe with infusion times of less 
than 30sec. Trimethadione (Abbott) 0, 50 or 
100 mg/kg was administered dissolved in 0.9% sodium 
chloride vehicle. Sodium valproic acid (Abbott) 0, 12.5 
or 25 mg/kg was administered sonified and freshly 
suspended in saline vehicle. Taurine (2-aminoethane- 
sulfonic acid; Sigma T-0625) was administered 0, 2, 20 
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Fig. 1. Behavioral interactions between morphine sulfate and trimethadione in grouped mice data 
presented as means and standard errors, based upon 9 determinations per data point. Broken lines 
represent animals which did not receive morphine, while solid lines represent those which did (as 
50 mg/kg, i.p.); open circles. triangles and solid circles respectively are 0, 50 and 100 mg/kg of trimetha- 
dione administered 30 min prior to morphine or vehicle. Extensive (5 hr) habituation immediately pre- 
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Fig 2. Interactions between morphine and sodium valproate in grouped mice. Motor activity is dis- 
played as means and standard errors based upon 9 determinations per data point. Broken tines represent 
groups not receiving morphine while solid lines received morphine 50 mg/kg. Open circles, triangles and 
solid circles represent 0. 12.5 and 25 mg/kg of sodium valproate injected 30min prior to morphine or 
vehicle. Extensive (5 hr) habituation immediately preceded testing Recording was based upon a remote 
sensing device beneath the cage as described in the text. 
Statistical analysis formation x = (Xi + 1)1’2 was therefore routinely 
All data are presented as means and standard employed. More detailed rationale for this particular 
errors of the mean. Further analyses involved 3- transformation is provided in Dixon and Massey 
factor analyses of variance. The factors were: pres- (1969). 
ence vs absence of morphine, presence vs absence of 
anticonvulsants, and time (min O-100), with repeated 
measures upon time). Due to an initial lack of hom- RESULTS 
ogeneity in variance across cells, it was felt desirable 
to transform scores prior to analysis. The trans- 
Three anticonvulsant drugs were examined for their 
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Fig 3. Interactions between taurine and morphine. Motor activity is displayed as means and standard 
errors based upon 9 determinations per data point. Broken lines represent groups not receiving mor- 
phine while solid lines are morphine injected (50mg/kg, i.p.); open circles and triangles, and solid 
triangles and circles represent 0, 2, 20 and 200 mgikg of taurine respectively, injected 30 min prior to 
morphine. Extensive (5 hr) habituation preceded testing. Recording was based upon a remote sensing 
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Fig. 4. Summary Figure displaying dose-response relationships for an enkephaiin analog (D-ala*-leu- 
enkephalinamide) after vehicle or intermediate values of trimethadione (50 mg/kg), sodium valproate 
(I 2.5 mg/kg) and taurine (20 mg/kg) injected in doses based upon Figures l-3. Mean motor activity per 
100 min session plus standard errors are displayed. Apparatus is described in Figures l-3 and text. 
the mouse. In comparison with vehicle, morphine was 
behaviorally facilitatory (Figs 1, 2. 3-respective F’s 
12.9. 15.7. 22.0. P < 0.0001. d.f. = 1,48: 1.48: 1.69). 
While none of the anticonvulsants had any facilita- 
tory effect upon normal activity (in all cases F ,< 1). 
two (trimethadione and sodium valproate) specifically 
fadilitated morphine activity (F’s for interac- 
tions = 11.1. 8.3; d.f. = 2.48; P < 0.0001). This inter- 
action was not present for taurine (F = 1.3; 
d.f. = 3,64: P = 0.3). Although reliable main effects 
for time were not present (F’s < 1.5, d.f. = 9,432; 
9.432; 9.655. P = 0.1). reliable effects of drug (i.e. mor- 
phine) by time (respective F’s = 4.7. 4.2, 3.8. 
d.f. =,9,432: 9.432; 9,655, P < 0.01) and three way in- 
teractions [F’s = 7.9, 6.2, 1.0; d.f. = 18.432; 18,432; 
24,655; P < 0.01 except taurine (NS) were found. 
Effects of anticonvulsants by time were not significant 
beyond chance (F’s < 1) except for taurine (F = 2.1: 
d.f. = 24,655; P < 0.001). 
Central injections of the enkephalin analog pro- 
duced a graded behavioral response and both tri- 
methadione and valproic acid shifted the enkephalin 
analog behavioral response curve to the left (Fig. 4). 
Taurine lacked this effect (Fig. 4). The behavioral 
findings are consistent both with the previous findings 
and the results of the last experiment. The main effect 
for the enkephalin analog was statistically reliable 
beyond chance (F = 13.1; d.f. = 3,64; P < 0.001) and 
both valproic acid and trimethadione significantly in- 
creased the level of opioid activity, shifting the dose- 
response curve (F’s = 9.9,8.9 respectively; d.f. = 9.64; 
P < 0.001; for taurine, F = 1.8, P -0.3). Time was 
not a main factor (all F’s < 1.2; d.f. = 8,597), 
although time did interact with enkephalin (F = 18.0: 
d.f. = 24,597) and, in addition, a three-way interaction 
was present (F = 3.1: d.f. = 72,597). 
DISCUSSION 
The present findings extend previous findings by 
Katz and Schmaltz (1979) to two novel but clinically 
used anticonvulsant drugs (trimethadione and sodium 
valproate). The effect was not present for taurine, at 
least within the present dose range: this may be 
explained by a number of unique postulated modes of 
action of the latter. Unlike other anticonvulsants, 
taurine is not an effective treatment for kindled seiz- 
ures which may represent an experimental analog of 
epilepsy (Wada, Osawa. Wake and Corcoran. 1975). 
Furthermore, in yet other preclinical models, taurine 
was shown to have a proconvulsant effect (Frigyesi 
and Lombardini. 1979). Although these findings do 
not rule out positive clinical findings, especially given 
procedural variations such as chronic administration. 
they do offer potential explanations of the discrepant 
actions of taurine in the present model. 
The findings with the analog confirm and extend 
previous studies on opiate-anticonvulsant interac- 
tions. As with morphine, an effect was seen for two 
compounds, valproic acid and trimethadione, but not 
for a third, taurine. The reasons for an absence of 
effect with the latter compound have already been 
suggested. The present findings suggest that the effects 
of anticonvulsants are not upon drug disposition, nor 
restricted to a single opiate. 
The findings, taken as a whole, suggest that actions 
of opiates which are altered by anticonvulsant treat- 
ment are behaviorally significant. The facilitation 
effects are not found in certain classes of therapeuti- 
cally effective compounds however, at least in the 
present testing circumstances. Thus, it may be con- 
cluded that anticonvulant facilitation of opiate effects 
is general, but apparently not universal. 
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